Glory Health Industry Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Glory Health Industry heeft een totaal eigen vermogen van CN¥13.7B en een totale schuld van CN¥22.1B, wat de schuld-eigenvermogensverhouding op 161.3% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥55.1B en CN¥41.4B.

Belangrijke informatie

161.3%

Verhouding schuld/eigen vermogen

CN¥22.13b

Schuld

Rente dekkingsratio	n/a
Contant	CN¥210.06m
Aandelen	CN¥13.72b
Totaal verplichtingen	CN¥41.36b
Totaal activa	CN¥55.08b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥28.7B ) van 84R } dekken niet de korte termijn passiva ( CN¥28.9B ).

Langlopende schulden: De kortetermijnactiva 84R ( CN¥28.7B ) overtreffen de langetermijnschulden ( CN¥12.4B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 159.8% ) 84R wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 84R is de afgelopen 5 jaar gedaald van 167.5% naar 161.3%.

Schuldendekking: De schuld van 84R wordt niet goed gedekt door de operationele kasstroom ( 0.5% ).

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van 84R op haar schulden goed worden gedekt door EBIT.

Glory Health Industry Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 59% undervalued after recent price drop

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought €171k worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven